Skip to main content
Fig. 1 | BMC Pharmacology and Toxicology

Fig. 1

From: Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania

Fig. 1

Box plots showing association between efavirenz plasma concentrations and the virological, immunological and clinical outcomes. Key: These graphs show efavirenz mid-dosing concentrations in children; central line represents median values while box and whiskers represent interquartile range and 10th –90th percentile, respectively, and individual points are outliers. Dotted lines represent 1 μg/mL and 4 μg/mL (Therapeutic range). a Efavirenz concentrations vs Viral load categories (< 400 copies/mL, 400–1000 copies/mL and > 1000 copies/mL). b Efavirenz concentrations vs CD4 categories (< 200 cells/μL, 200–499 cells/μL, > 500 cells/μL). c Efavirenz concentrations vs Nutritional status (MUAC). d Efavirenz concentrations vs weight bands in Kg and efavirenz doses in mg

Back to article page